DSM Biomedical Announces New License Agreements with Global Medical Device Manufacturers

DSM Biomedical and its Berkeley-based operation, DSM PTG, yesterday announced that the company has entered into six multi-year licensing agreements with global medical device manufacturers in the orthopaedic, cardiovascular, vascular and urology fields. The new agreements allow DSM to work in conjunction with leading medical device manufacturers throughout the various phases of development, prototyping, manufacturing and processing of product commercialisation. Specifically, these medical device companies will be in a position to leverage the track record of DSM Biomedical’s advanced biomedical materials, including BionatePCU, CarboSil TSPCU and ComfortCoat medical coatings in applications such as total disk replacement, spinal stabilisation, continuous glucose monitoring, cardiac rhythm management, neurostimulation, catheters and heart assist devices.

DSM Biomedical actively explores licensing opportunities, setting up business models that are typical of knowledge-based rather than production-based businesses, including the licensing of intellectual property. Working with medical device and biopharmaceutical manufacturers in the United States and Europe, in various fields including orthopaedics, ophthalmics, cardiovascular, vascular and urology, the company is certified to ISO 9001 and/or ISO 13845 standards.

Tags: DSM Biomedical, DSM PTG